FTC: Illumina/GRAIL antitrust case

Federal Trade Commission · 9401 · decided Mar 30, 2021 · Closed

Decision

The FTC challenged Illumina's vertical acquisition of cancer test developer GRAIL, alleging it would let Illumina disadvantage GRAIL's rivals that depend on its sequencers.

Related cases

When	Case	Kind	Status	Filed
Sep 25Telephone Conference Todaynext date	United States v. Visa (debit)Telephone ConferenceActiveAntitrustS.D. N.Y.	Antitrust	Active	Sep 24, 2024
Oct 2Joint proposed final judgment due in 7dnext date	United States v. Google (ad tech)Joint proposed final judgment dueDecidedAntitrustE.D. Va.	Antitrust	Decided	Jan 24, 2023
Jul 23Filed 64d agofiled	EU Commission: Google DMA finesDecidedAntitrustEuropean CommissionEUR 890 million	Antitrust	Decided	Jul 23
Jul 9Filed 78d agofiled	EU Commission: SAP ERP support commitmentsClosedAntitrustEuropean Commission	Antitrust	Closed	Jul 9
Jun 25Filed 92d agofiled	EU Commission: AWS and Azure DMA cloud investigationActiveAntitrustEuropean Commission	Antitrust	Active	Jun 25
Jun 9Filed 4mo agofiled	EU Commission: Meta WhatsApp AI interim measuresActiveAntitrustEuropean Commission	Antitrust	Active	Jun 9
May 14Filed 4mo agofiled	CMA: Microsoft business software SMS investigationActiveAntitrustUK CMA	Antitrust	Active	May 14
Feb 5Filed 8mo agofiled	Bundeskartellamt: Amazon price control prohibitionDecidedAntitrustBundeskartellamtEUR 59 million	Antitrust	Decided	Feb 5